Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 4.557E-10 | 1.654E-06 | FABP2, FABP3, FABP4, FABP5 |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 1.818E-06 | 1.885E-03 | NR1H4, PPARA, PPARD |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 3.199E-06 | 3.029E-03 | NR1H4, PPARA, PPARD |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 4.704E-06 | 4.268E-03 | FABP3, PPARA, PPARD |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 8.039E-06 | 6.405E-03 | FABP3, NR1H4, TLR2 |
BP | GO:0008152; metabolic process | GO:0071073; positive regulation of phospholipid biosynthetic process | 8.667E-06 | 6.508E-03 | FABP3, NR1H4 |
BP | GO:0008152; metabolic process | GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter | 1.323E-05 | 9.006E-03 | PPARA, PPARD |
MF | GO:0005488; binding | GO:0036041; long-chain fatty acid binding | 1.323E-05 | 9.006E-03 | FABP3, PPARD |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa03320 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.804E-13 | 9.252E-12 | FABP2; FABP3; FABP4; FABP5; PPARA; PPARD |
hsa04923 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.416E-04 | 5.636E-03 | FABP4; TSHR |
hsa04024 | cAMP signaling pathway_Homo sapiens_hsa04024 | 4.206E-03 | 4.627E-02 | PPARA; TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR |
C00-D49: Neoplasms | Cancer | C00-C96 | TLR2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | PPARD; PPARD |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | PPARD |
C00-D49: Neoplasms | Melanoma | C43 | TLR2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | PPARD |
C00-D49: Neoplasms | Myelodysplastic syndrome | D46 | TLR2 |
NA: NA | Dyslipidemia | NA | PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases | Dyslipidaemias | E78 | PPARD; PPARD |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 1 diabetes | E10 | PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic disorders | E70-E89 | PPARD |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
K00-K95: Diseases of the digestive system | Non-alcoholic fatty liver disease | K76.0 | PPARD |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TLR2 |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases | Autoimmune diabetes | E08-E13 | TLR2 |
S00-T88: Injury, poisoning and certain other consequences of external causes | Radiation sickness | T66 | TLR2 |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | PPARD |
C00-D49: Neoplasms | Prostate cancer | C61 | TLR2 |
C00-D49: Neoplasms | Pancreatic cancer | C25 | TLR2 |